Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)
Agrupación estratéxica de I+D+i
![Foto de Agrupación Estratéxica en Xestión e Produción sustentable de Biorrecursos (BioReDes)](/img/noimage.png)
![Foto de Complexo Hospitalario Universitario da Coruña](/img/noimage_org.png)
Complexo Hospitalario Universitario da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (23)
2024
-
Toxicity of zinc oxide nanoparticles: Cellular and behavioural effects
Chemosphere, Vol. 363
2023
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
2022
-
Extremophilic cyanobacteria from thermo-mineral springs of spas in Atlantic environments
Systematics and Biodiversity, Vol. 20, Núm. 1, pp. 1-15
-
Generalized implementation of reflex testing of hepatitis C in Galicia: Results for reflection
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 9, pp. 483-488
-
Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria
Open Forum Infectious Diseases, Vol. 9, Núm. 9
2021
-
Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis: A Multicenter Matched Cohort Study
Open Forum Infectious Diseases, Vol. 8, Núm. 6
-
The role of intestinal microbiota in the colorectal carcinogenesis
Foundations of Colorectal Cancer (Elsevier), pp. 495-512
2019
-
HIV co-infection in HTLV-1 carriers in Spain
Virus Research, Vol. 266, pp. 48-51
2015
-
Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study
Medicine (United States), Vol. 94, Núm. 43
-
Left-sided infective endocarditis in patients with liver cirrhosis
Journal of Infection, Vol. 71, Núm. 6, pp. 627-641
2014
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
2013
-
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes
Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 9, pp. 1994-2002
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
2010
-
Isolation and Characterization of Potentially Pathogenic Antimicrobial-Resistant Escherichia coli Strains from Chicken and Pig Farms in Spain
Applied and Environmental Microbiology, Vol. 76, Núm. 9, pp. 2799-2805
2008
-
Staphylococcus spp. en España: Situación actual y evolución de la resistencia a antimicrobianos (1986-2006)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 5, pp. 269-277
2007
2006
-
Isolation and biological characterization of HIV-1 BG intersubtype recombinants and other genetic forms circulating in Galicia, Spain
Journal of Medical Virology, Vol. 78, Núm. 12, pp. 1520-1528
2005
-
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Journal of Medical Virology, Vol. 77, Núm. 1, pp. 23-28
2004
-
Total HCV core antigen assay: A new marker of HCV viremia and its application during treatment of chronic hepatitis C
Journal of Virological Methods, Vol. 120, Núm. 2, pp. 173-177